This hinted at the possibility of the peptide having preventive or protective potential against the immediate consequences of traumatic brain injury in experimental models
But they may improve healing after surgery, potentially reducing retear rates and accelerating functional recovery
Research & Evidence Disclaimer: Information presented in this article includes references to preclinical (animal and laboratory) research
In September 2023, the FDA added BPC-157 to its Category 2 list of bulk drug substances under its Interim Policy on Compounding, meaning 503A compounding pharmacies and 503B outsourcing facilities are barred from using it in compounded preparations
Reddy's Laboratories Inc #43598067611 ,for, Item ID- #462548 American Regent #00517003125 ,for, Item ID- #1120326 Amneal Pharmaceuticals LLC #70121104902 ,for, Item ID- #1250666 NorthStar Rx #72603014601 ,for, Item ID- #1246630 Piramal Critical Care #66794022841 ,for, Item ID- #1217993 Meitheal Pharmaceuticals #71288080702 ,for, Item ID- #1010119 Auromedics Pharmaceuticals #55150019410 ,for, Item ID- #1200636 Xiromed LLC #70700017223 ,for, Item ID- #501703 Fresenius USA #63323042410 ,for, Item ID- #1091140 American Regent #00517671010 ,for, Item ID- #479124 Fresenius USA #63323011710 ,for, Item ID- #805389 Hikma Pharmaceuticals USA #00143978310 ,for, Item ID- #1238084 Pfizer #00409012525 ,for, Item ID- #1246640 Piramal Critical Care #66794022941
